TTVR Early Feasibility Study

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 20, 2020

Primary Completion Date

July 30, 2026

Study Completion Date

July 30, 2031

Conditions
Tricuspid Regurgitation
Interventions
DEVICE

Intrepid™ TTVR System

Device: Intrepid™ TTVR System

Trial Locations (20)

10029

RECRUITING

The Mount Sinai Hospital, New York

10032

RECRUITING

Columbia University Medical Center/NYPH, New York

10467

RECRUITING

Montefiore Medical Center, The Bronx

17101

RECRUITING

UPMC Pinnacle Harrisburg Campus, Harrisburg

30308

RECRUITING

Emory University Hospital Midtown, Atlanta

35233

RECRUITING

University of Alabama at Birmingham (UAB) Hospital, Birmingham

43214

RECRUITING

OhioHealth Riverside Methodist Hospital, Columbus

44106

RECRUITING

University Hospitals Cleveland Medical Center, Cleveland

45242

RECRUITING

The Christ Hospital, Cincinnati

48109

RECRUITING

University of Michigan, Ann Arbor

49503

RECRUITING

Corewell Health, Grand Rapids

53125

RECRUITING

Aurora St. Lukes Medical Center, Milwaukee

55407

RECRUITING

Abbott Northwestern Hospital, Minneapolis

59802

RECRUITING

Providence Saint Patrick Hospital, Missoula

77030

RECRUITING

Houston Methodist Hospital, Houston

85016

RECRUITING

Abrazo Arizona Heart Hospital, Phoenix

90048

RECRUITING

Cedars Sinai Medical Center, Los Angeles

94115

RECRUITING

California Pacific Medical Center, San Francisco

97239

RECRUITING

Oregon Health & Science University, Portland

06102

RECRUITING

Hartford Hospital, Hartford

Sponsors
All Listed Sponsors
lead

Medtronic Cardiovascular

INDUSTRY

NCT04433065 - TTVR Early Feasibility Study | Biotech Hunter | Biotech Hunter